14.30
Anika Therapeutics Inc Aktie (ANIK) Neueste Nachrichten
(ANIK) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Anika Therapeutics (ANIK) Holds Steady Near Support Amid Low VolumeMonthly Profile - newsline.com
Anika Therapeutics Q1 2026 Earnings: Massive EPS Beat Fuels OptimismConsensus Forecast Report - newsline.com
Anika reports inducement grants - Medical Buyer
Anika Therapeutics grants 3,360 RSUs to new employee as inducement under Nasdaq rules. - Pluang
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
New Anika hire receives 3,360 stock units as job inducement - Stock Titan
Anika (NASDAQ: ANIK) CEO exercises RSUs, withholds shares to cover tax - Stock Titan
Anika Therapeutics introduces proprietary Hyaff material for next generation regenerative applications - Traders Union
How (ANIK) Movements Inform Risk Allocation Models - Stock Traders Daily
Anika Therapeutics (ANIK) Holds Steady Near Support as Slight Decline PersistsIV Contraction - thelegaladvocate.com
Anika Therapeutics (ANIK) Hovers Near Support With Minimal Price MovementResistance Breakout Stocks - newsline.com
Anika Therapeutics (ANIK) Slides 1.6% Amidst Market Pressure – Key Levels to WatchOrder Block - The Legal Advocate
ANIK Stock Analysis: Anika Therapeutics Inc. gains 3.31 percent daily, trades at 14.98 dollar - Newser
ORIC Stock Heads Into Weekend as Cancer-Trial Deadline Approaches - Bez Kabli
Trading Systems Reacting to (ANIK) Volatility - Stock Traders Daily
Anika Therapeutics (ANIK) Q1 2026 Earnings: Surprise EPS Beat Amid Revenue UncertaintyAnnual Financial Report - newsline.com
ANIK Q1 2026 Earnings: Surprise Profit Swing as Anika Therapeutics Beats ExpectationsAnnual Earnings Summary - Newser
Why Is Anika Therapeutics, Inc. (ANIK) Stock Up Today? - Meyka
Anika Therapeutics Signals Momentum Amid Regulatory Risks - The Globe and Mail
Anika Therapeutics honors Clinical Trials Day as it advances patient outcomes - Traders Union
Anika maintains 2026 revenue guidance of $114M-$122.5M while highlighting Integrity growth and Hyalofast FDA response work - MSN
Why Is Anika Therapeutics, Inc. (ANIK) Stock Down Today? - Meyka
Anika Therapeutics invites ESSKA Congress delegates to explore advances in HA-based cartilage repair - Traders Union
About Us | Oil & Gas JournalAnika Therapeutics Inc.Common Stock (Nasdaq:ANIK) Stock Quote - FinancialContent
TradingKey - TradingKey
How Anika Therapeutics Inc. (ANIK) Affects Rotational Strategy Timing - Stock Traders Daily
Anika Therapeutics (ANIK) Eps Diluted (TTM) - Zacks Investment Research
How Anika (ANIK) margins compare to industry leaders (+0.13%) 2026-05-08High Attention Stocks - newser.com
ANIK (Anika) Q1 earnings crush estimates by 265%, but shares barely budge amid revenue softness.Earnings Forecast Report - newsline.com
Anika Therapeutics explores why skin heals rapidly but tendons and cartilage lag in recovery - Traders Union
Number of shareholders of Anika Therapeutics Inc. – NASDAQ:ANIK - TradingView
Insider Buying: HENNEMAN JOHN B III Acquires 5,000 Shares of Ani - GuruFocus
Anika Therapeutics Q1 2026 earnings preview - MSN
Anika Therapeutics director John Henneman buys $73,319 in shares By Investing.com - Investing.com Canada
Anika Therapeutics director John Henneman buys $73,319 in shares - Investing.com
Anika Therapeutics (ANIK) director adds 5,000 shares in open-market buy - Stock Titan
President of Anika Therapeutics Picks Up 51% More Stock - Yahoo Finance
Anika Therapeutics (NASDAQ:ANIK) Rating Lowered to "Buy" at Wall Street Zen - MarketBeat
Anika Therapeutics Q1 2026 Financial Results: Revenue, Losses, and Key Financial Statements Overview - minichart.com.sg
ANIK | Anika Therapeutics Inc Insider Trading - Quiver Quantitative
Anika Therapeutics Projects $114 Million Revenue Growth for Fiscal 2026 - HarianBasis.co
Insider Buying: Stephen Griffin Acquires Shares of Anika Therape - GuruFocus
Anika Therapeutics (NASDAQ:ANIK) CEO Purchases $149,938.00 in Stock - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):